Despite a surge in awareness and investment surrounding women's health, a new cross-sector report reveals where ...

Researchers identified three obesity subtypes in new research. In one subtype, individuals have low GLP-1 and rapid gastric ...

Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive results from a Phase 2b trial evaluating the safety and efficacy of ...

The mandate approved today follows the adoption on 11 May 2026 of a regulation extending data protection periods regarding ...

EClinCloud, an AI technology company for clinical research that builds a unified clinical cloud platform and endpoint ...

Endocrine systems and metabolic diseases affect the endocrine system and disrupt metabolism. Examples include diabetes and goiter.

From insulin inhalers to epinephrine nasal sprays, new delivery systems are making some lifesaving drugs easier to take.

Many healthcare professionals do not attribute symptoms such as fatigue, mood changes or sleep disruptions to menopause, leading to a missed opportunity for proper treatment in midlife women, ...

The detection effort enlisted roughly 950 AI agents that spent more than 21 hours combing through DNA sequence databases.

“Would you like your receipt?” It’s a question you’re likely to hear every time you pop into the grocery store or stop for a ...

Foundayo 17.2 mg was associated with 1.5% greater weight loss and 0.3% greater A1C reduction than oral semaglutide 25 mg at 52 weeks. These additional analyses build on findings o ...

Immune checkpoint inhibitor (ICI) therapy triggers complications that are currently attributed solely to immune activation.